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Purpose: Several studies have demonstrated the superiority of endorectal coil 
magnetic resonance imaging (MRI) over pelvic phased-array coil MRI at 1.5 Tesla 
for local staging of prostate cancer. However, few have studied which evaluation is 
more accurate at 3 Tesla MRI. In this study, we compared the accuracy of local 
staging of prostate cancer using pelvic phased-array coil or endorectal coil MRI at 
3 Tesla. Materials and Methods: Between January 2005 and May 2010, 151 pa-
tients underwent radical prostatectomy. All patients were evaluated with either pel-
vic phased-array coil or endorectal coil prostate MRI prior to surgery (63 endorec-
tal coils and 88 pelvic phased-array coils). Tumor stage based on MRI was 
compared with pathologic stage. We calculated the specificity, sensitivity and ac-
curacy of each group in the evaluation of extracapsular extension and seminal ves-
icle invasion. Results: Both endorectal coil and pelvic phased-array coil MRI 
achieved high specificity, low sensitivity and moderate accuracy for the detection 
of extracapsular extension and seminal vesicle invasion. There were statistically 
no differences in specificity, sensitivity and accuracy between the two groups. 
Conclusion: Overall staging accuracy, sensitivity and specificity were not signifi-
cantly different between endorectal coil and pelvic phased-array coil MRI.
Key Words:    Prostatic neoplasms, magnetic resonance imaging, neoplasm stag-
ing, comparative study
INTRODUCTION
Prostate cancer remains a major health concern among the male population. Cur-
rently, a rapid increase in prostate-specific antigen (PSA) screening has resulted in 
an increased detection rate of small cancers and an increased incidence of this dis-
ease. In the evaluation of patients with prostate cancer, the most important factor 
affecting a patient’s prognosis and choice of management method is the disease 
stage at the time of diagnosis.1 For several decades, various imaging modalities 
have been assessed for staging of prostate cancer. Among these imaging modali-
ties, magnetic resonance imaging (MRI), with its excellent soft-tissue contrast, 
provides high-resolution images of the prostate and surrounding structures.2-4Local Staging Accuracy of Prostate Cancer Using 3 Tesla MRI
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tient had difficulty or was contraindicated for ERC inser-
tion (e.g., prior anorectal surgery, inflammatory bowel dis-
ease, or high anal sphincter tension), the patient underwent 
MRI with a PAC.
MR imaging analysis
All patients were randomly scheduled to undergo 3 Tesla 
MRI (Signa Excite, GE Medical Systems, Waukesha, WI, 
USA) with either an ERC or a PAC prior to radical prosta-
tectomy. In the MRI examination using a PAC (Pelvic Ar-
ray, GE Healthcare, Waukesha, WI, USA), a commercially 
available eight-element standard PAC was placed around 
the pelvic area with the patient in the supine position. After 
localizing images were obtained, T2-weighted fast spin-
echo image series in the transverse, sagittal, and coronal 
planes were obtained. Radiofrequency power deposition 
from the spin-echo train was reduced using hyperechoes.12 
The T2-weighted imaging scan parameters were as follows: 
TR/TE, 3700/104 ms; slice thickness, 4 mm; interslice gap, 
0.4 mm; 320×224 matrix; FOV, 160×160 mm; number of 
excitations, 3; and scan time, 8 minutes 20 seconds. 
In the MRI examination using an ERC (MR Innerva, 
Medrad, Pittsburgh, PA, USA), a commercially available 
balloon-covered expandable ERC was inserted with the pa-
tient in the left lateral decubitus position. The balloon was 
then inflated with 40-60 mL of de-mineralized water. The 
patient was then placed in the supine position, and bowel 
movements were suppressed with an intramuscular injec-
tion of 1 mg of glucagon. An ERC localization image series 
was obtained, and subsequently, T2-weighted fast spin-
echo images were obtained with the use of hyperechoes in 
the transverse, sagittal, and coronal planes. Sequence pa-
rameters were as follows: TR/TE, 3700/104 ms; slice thick-
ness, 4 mm; interslice gap, 0.4 mm; 320×224 matrix; FOV, 
160×160 mm; number of excitations, 3; and scan time, 8 
minutes 20 seconds. Of these 151 patients, 63 patients un-
derwent prostate MRI with an ERC, and 88 patients under-
went prostate MRI with a PAC. Radiologic interpretations 
were made by consensus of two radiologists. One radiolo-
gist had more than 10 years of experience with prostate 
MRI with the use of a PAC at 1.5 Tesla and 3 years of ex-
perience with the use of an ERC at 1.5 Tesla. The other ra-
diologist had 2 years of experience with prostate MRI with 
the use of both ERC and PAC at 1.5 Tesla. The criteria for 
the diagnosis of extraprostatic extension included a bulge in 
the contour of the prostate, obliteration of the rectoprostatic 
angle, thickening or disruption of the prostatic capsule, an 
Although there has been much debate regarding whether 
MRI should be used routinely for the diagnosis of prostate 
cancer, for over two decades, MRI has improved our ability 
to delineate localized versus locally advanced prostate can-
cer.5 However, it has poor sensitivity for the detection of 
microscopic spread. Hence, various MR techniques, such 
as endorectal coil, higher Tesla and diffusion-weighted 
MRI, have been proposed to improve the morphological 
imaging quality of prostate cancers. To date, several studies 
have suggested that MRI using an endorectal coil (ERC) is 
the most promising technique for the detection and staging 
of prostate cancer. Especially, at standard clinical field 
strengths of 1.5 Tesla, an ERC is necessary to obtain a suf-
ficiently high signal-to-noise ratio (SNR) with subsequent 
spatial resolution, which allows for more reliable cancer de-
lineation in a clinically reasonable timeframe.6-8 However, 
the use of an ERC is more time-consuming, entails higher 
costs and causes greater discomfort in the patient.9,10 More-
over, at higher magnetic field strengths, such as 3 Tesla, 
SNR increases in standard MRI, and the need for an ERC 
for the detection or localization of prostate cancer at this 
magnetic field strength has not yet been resolved.11 There-
fore, it is important to determine whether an ERC remains 
necessary or whether a pelvic phased-array coil (PAC) 
could suffice for staging of prostate cancer at 3 Tesla MRI. 
Thus, we compared the prostate cancer local-staging per-
formance of ERC and PAC MRI at 3 Tesla along with his-




Between January 2005 and May 2010, 151 consecutive pa-
tients, who met our inclusion criteria and had biopsy-prov-
en prostate cancer, underwent radical prostatectomy at our 
institution. Of these patients, 33 patients underwent open 
radical retropubic prostatectomy, while 118 patients under-
went robotic-assisted laparoscopic surgery. All surgeries 
were performed by one oncologic urologist who had expe-
rience in more than 100 cases of radical prostatectomies. 
Exclusion criteria were contraindications for MRI (e.g., 
pacemaker and metal cerebral clips) as well as severe claus-
trophobia. Additionally, patients who received neoadjuvant 
hormonal therapy or radiotherapy after MRI examination 
and patients who had undergone a prostate biopsy and MRI 
within 3 weeks of each other were also excluded. If a pa-Bum Soo Kim, et al.
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extent of each cancer focus, and radical distance of each ex-
tracapsular penetration were determined by a genitourinary 
histopathologist with 13 years of experience who was blind-
ed to the MRI results. The MRI findings were compared 
with the histopathologic findings of the radical prostatecto-
my specimen in each patient (Fig. 1).
Statistical analysis
Sensitivity, specificity, positive prediction values, negative 
prediction values, and overall accuracy in prediction of ex-
tracapsular extension and seminal vesicle invasion were 
calculated by dichotomizing the readings. Calculated SNR 
values of each sequence were expressed as the mean±SD 
and compared using Student’s t-test. Statistical significance 
differences in sensitivity, specificity, positive prediction val-
ue, negative prediction value, and accuracy between the 
ERC MRI group and PAC MRI group were determined us-
ing the Chi square test. All statistical analyses were con-
ducted using SPSS 12.0 for Windows, and statistical signif-
icance was accepted at a p-value less than 0.05.
infiltrative strand in the periprostatic fat, or asymmetry of the 
neurovascular bundle. Seminal vesicle invasion was de-
fined by the presence of abnormal tissue with low signal in-
tensity within the seminal vesicle or dilatation of the semi-
nal vesicle with asymmetry on T2-weighted images. T1-
weighted images were used to rule out false-positive findings 
caused by post-biopsy hemorrhage; if a low signal intensity 
lesion on a T2-weighted image matched a high signal inten-
sity, then this area was considered a biopsy hematoma. Fur-
thermore, SNRs of the entire prostate region for ERC and 
PAC MRI groups were calculated.
Histopathologic examination
After excision, prostatectomy specimens were fixed over-
night in 10% neutral buffered formaldehyde and coated 
with India ink. Four-millimeter-interval whole-mount sec-
tions were cut at a plane likewise to the transverse MRI 
plane. All sections were routinely embedded in paraffin. Tis-
sue sections of 5 μm were prepared and stained with hema-
toxylin-eosin. The exact localization, volume, Gleason score, 
Fig. 1. Comparison of a T2-weighted fast spin-echo magnetic resonance image at 3 Tesla and a corresponding axial whole-mount-sec-
tion histopathologic slice (A) example of a tumor with a 2-mm radial distance of extracapsular extension (arrow) (prostate-specific anti-
gen level, 7.8 ng/mL; final Gleason score, 3+4; stage, pT3a) that was detected with ERC MRI in a 61-year-old man, and histopathologic ex-
amination confirmed the presence of extracapsular entension at the left lateral side (circle) (B) example of a tumor with a 8-mm radial 
distance of extracapsular extension (arrow) (prostate-specific antigen level, 10.6 ng/mL; final Gleason score, 4+3; stage, pT3a) that was 
detected with PAC MRI in a 64-year-old man, and histopathologic examination confirmed the presence of extracapsular entension at the 
right dorsal side (circle). ERC, endorectal coil; PAC, phased-array coil; MRI, magnetic resonance imaging.
A
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with extraprostatic extension and 13 patients with seminal 
vesicle invasion. Of 88 patients, PAC MRI discovered sus-
pected extraprostatic extension in 15 patients and suspected 
seminal vesicle invasion in 9 patients, while histopatholog-
ic analysis revealed 48 patients with extraprostatic exten-
sion and 21 patients with seminal vesicle invasion. The sen-
sitivity, specificity, and overall accuracy for the detection of 
extraprostatic extension were 33.3%, 96.6%, and 63.5% for 
ERC MRI and 31.3%, 97.5%, and 61.4% for PAC MRI, re-
spectively (Table 2). Additionally, the sensitivity, specifici-
ty, and overall accuracy for the detection of seminal vesicle 
invasion were 46.2%, 92.0%, and 82.5% for ERC MRI and 
RESULTS
 
Table 1 summarizes the clinicopathologic data of the ERC 
MRI and PAC MRI groups. The mean age, mean preopera-
tive PSA level, average time interval between prostate bi-
opsy and MRI examination, ratio of open/robotic surgery, 
Gleason score at biopsy, and prostatectomy were not signif-
icantly different between the two groups. Of 63 patients, 
ERC MRI discovered suspected extraprostatic extension in 
11 patients and suspected seminal vesicle invasion in 6 pa-
tients, while histopathologic analysis revealed 33 patients 
Table 1. Clinicopathologic Characteristics of the Patients
Endorectal coil MRI Pelvic phased-array coil MRI p value
No. of patients 63 88
Mean age (yrs)*   64.8 (47-76)   66.8 (55-76) 0.127
Mean preoperative PSA level (ng/mL)*     11.69 (3.0-37.0)     12.36 (4.0-38.0) 0.386
Interval between biopsy and MRI (days)* 28.18 (22-45) 27.65 (24-45) 0.707
Operation method (ORRP/RARP) 13/50 20/68 0.759
Gleason score at biopsy
† 0.757
    6    35 (55.5)    50 (56.8)
    7    18 (28.6)    22 (25.0)
    8      9 (14.3)    12 (13.6)
    9    1 (1.6)    4 (4.5)
Gleason score at prostatectomy
† 0.544
    6    19 (30.2)    23 (26.1)
    7    28 (44.4)    42 (47.7)
    8    13 (20.6)    14 (15.9)
    9    3 (4.8)      9 (10.2)
MRI, magnetic resonance imaging; PSA, prostate specific antigen; ORRP, open retropubic radical prostatectomy; RARP, robotic-assisted laparoscopic radi-
cal prostatectomy.
*Data in parentheses are ranges.
†Data in parentheses are percentages.
Table 2. Comparison of Local Staging Performance between Endorectal Coil and External Surface Coil MRI for Detecting Ex-
traprostatic Extension and Seminal Vesicle Invasion of Prostate Cancer
Endorectal coil MRI Pelvic phased-array coil MRI p value
ECE
    Sensitivity 11/33 (33.3) 15/48 (31.3) 0.967
    Specificity 29/30 (96.6) 39/40 (97.5) 0.836
    Positive prediction value 11/12 (91.7) 15/16 (93.8) 0.811
    Negative prediction value 29/51 (56.9) 39/72 (54.2) 0.814
    Accuracy 40/63 (63.5) 54/88 (61.4) 0.858
SVI
    Sensitivity   6/13 (46.2)   9/21 (42.9) 0.664
    Specificity 46/50 (92.0) 62/67 (92.5) 0.914
    Positive prediction value   6/10 (60.0)   9/14 (64.3) 0.604
    Negative prediction value 46/53 (86.8) 62/74 (83.8) 0.884
    Accuracy 52/63 (82.5) 71/88 (80.7) 0.978
MRI, magnetic resonance imaging; ECE, extracapsular extension; SVI, seminal vesicle invasion.
Data in parentheses are percentages.Bum Soo Kim, et al.
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extension, the sensitivity, specificity, and accuracy of en-
dorectal coil MRI has been reported to range from 13-71%, 
47-97%, and 58-91%, respectively, whereas for the detec-
tion of seminal vesicle invasion, the sensitivity, specificity, 
and accuracy of endorectal MRI has been reported to range 
from 33-71%, 83-99%, and 80-95%, respectively.21-23 In our 
study, the sensitivity, specificity, and accuracy of endorectal 
coil MRI for the detection of extraprostatic extension was 
33.3%, 96.6%, and 63.5%, respectively, and the sensitivity, 
specificity, and accuracy of the detection of seminal vesicle 
invasion was 46.2%, 92.0%, and 82.5%, respectively. 
This wide range of specificities and sensitivities of MRI 
in the assessment of extraprostatic extension and seminal 
vesicle invasion is due to a combination of factors includ-
ing considerable interobserver variability14,24 as well as the 
lack of standardized diagnostic criteria.25,26 In addition, the 
oncologic characteristics of preoperative patients are also 
important factors. Recent studies demonstrated that sensi-
tivity was higher in poorly differentiated prostate cancer 
and/or intermediate and high-risk groups.7,27 Low-risk groups 
and well-differentiated cancer groups may not usually have 
extraprostatic extension. However, they have a greater 
chance of microscopic invasion rather than gross invasion, 
if they indeed do have extraprostatic invasion. Further, MRI 
still has a limitation in the detection of microscopic spread. 
A large population in the low-risk group (Gleason score 6 
and less than 10 of preoperative serum PSA level) and a 
high upgrading rate in Gleason scores after radical prosta-
tectomy may be one of the main factors of low sensitivity 
in our study. In addition, low sensitivity may be attributable 
to post-biopsy changes. While the amount of hemorrhaging 
often varies, it can be profound and involve large segments 
42.9%, 92.5%, and 80.7% for PAC MRI, respectively (Ta-
ble 2). Statistically, there were no significant differences in 
sensitivity, specificity, and accuracy between the two groups. 
The sensitivity of both ERC and PAC MRI for the detec-
tion of extraprostatic extension and seminal vesicle inva-
sion tended to increase in the intermediate/high risk group 
(Table 3).
The SNR of ERC MRI was 14.75±3.92 and 11.53±3.44 
for PAC MRI. Although the SNR was slightly higher in the 
ERC MRI group, there was no statistically significant dif-
ference (p=0.081).
DISCUSSION
In the past, the use of computed tomography and MRI to 
evaluate the local extent of prostate cancer was not routine-
ly recommended because of low sensitivity and accompa-
nying low cost-effectiveness.13-15 However, with continuous 
developments in better technology, MRI has become in-
creasingly implemented for the diagnosis and staging of 
prostate cancer. Recent studies reported that dynamic con-
trast-enhanced MRI are useful for the staging work-up of 
prostate cancer.16-18 In addition, proton MR spectroscopic 
imaging and functional MRI can further improve the detec-
tion rate of cancer while enhancing the assessment of tu-
mors’ aggressiveness, volume, and extent.16-19 Especially, 
endorectal coil MRI seems to be the most accurate imaging 
modality available for the evaluation of extensiveness of 
prostate cancer, replacing pelvic phased-array MRI of the 
prostate due to higher spatial and contrast resolution, im-
proving image quality.8,20 For the detection of extraprostatic 
Table 3. Local Staging Performance of the Patients Stratified in the Low and Intermediate/high Risk Groups for Preoperative 
Endorectal Coil and External Surface Coil MRI
Low risk* Intermediate/high risk
†
ERC PAC ERC PAC
ECE
    Sensitivity 0/13 (0) 0/19 (0) 11/20 (55) 15/29 (51.7)
    Specificity   18/18 (100)   24/24 (100)    11/12 (91.7) 15/16 (93.8)
    Accuracy    18/31 (58.1)    26/43 (60.5)    22/32 (68.8) 30/45 (66.7)
SVI
    Sensitivity   0/3 (0)   0/4 (0)   6/10 (60)   9/17 (52.9)
    Specificity    28/30 (93.3)    38/41 (92.7) 18/20 (90) 24/26 (92.3)
    Accuracy    28/33 (84.8)    38/45 (84.4) 24/30 (80) 33/43 (76.7)
ERC, endorectal coil; PAC, pelvic phased-array coil; ECE, extracapsular extension; SVI, seminal vesicle invasion; PSA, prostate-specific antigen.
Data in parentheses are percentages.
*Low risk: clinical stage T1c to T2a and PSA ≤10 and Gleason score 6.
†Intermediate/high risk: clinical stage ≥T2b or PSA >10 or Gleason score ≥7.Local Staging Accuracy of Prostate Cancer Using 3 Tesla MRI
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the local staging of prostate cancer.
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